People · Operator
Named in public records as an officer, director or promoter · active 2018–2024 · Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| 23andMe, Inc. | — | Other Technology | Series D+ | $819.5M | $2.3B | 2018 |
| Zura Bio Ltd | — | Biotechnology | Series D+ | $128.4M | $1.3B | 2023 |
Steven Schoch at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Steven Schoch on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Patrick Chung | 1 | 10 |
| Esther Dyson | 1 | 9 |
| ROELOF BOTHA | 1 | 6 |
| Amit Munshi | 1 | 5 |
| Richard Scheller | 1 | 4 |
| Michael Howell | 1 | 3 |
| Andrew Page | 1 | 3 |
| Patrick S. Chung | 1 | 2 |
| Kim Davis | 1 | 2 |
| Sandeep Kulkarni | 1 | 2 |
| Neal Mohan | 1 | 2 |
| Linda Avey | 1 | 2 |
| Parvinder Thiara | 1 | 1 |
| Garry Neil | 1 | 1 |
| Christopher Cabell | 1 | 1 |
| Kathy L. Hibbs | 1 | 1 |
| Neal S. Mohan | 1 | 1 |
| Dean L. Schorno | 1 | 1 |
| Roelof L. Botha | 1 | 1 |
| Esther S. Dyson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.